Muscle Pharm Corporation (MSLPQ)

[jeff_green]

Another FACT! according to 2014 10K. BZNE generated $10m of revenue in 2014 at a 20% cash loss. BZNE was $2m cash burn not counting the stock repurchase @ $10 a share that now shows an additional $6m cash loss.

Take BZNE revs out as it is non core and a 20% ongoing cash loser and MSLP is running at a $120m annual revenue run rate on MSLP products.

Those forecasting $220m - $365m in revenue are in Fantasy Land.

$120m (reve) * 77% (cogs) = $28.6 - $76m SGA = $47.4m loss

Now add in the $2m BZNE loss and the likely loss would be $50m in 2015 if MSLP could raise enough fresh capital to stay afloat.

That is a more likely forecast as it is based on proven historical metrics as of today.

All the above numbers are the factual metrics reported by MSLP to the SEC for Q4 2014 and extrapolated out for 2015. No pipe dreams. Just FACTS!